Scientists are always looking for new ways of treating mental illness. Indeed, it was only recently that we learned of new research undertaken by 34-year-old neuroscientist Rebecca Brachman. Brachman has been busy developing a new treatment that builds a kind of mental robustness, which will allow individuals to subject themselves to harrowing events without having to relive the trauma afterwords.
Brachman found that ketamine – a drug that has long been touted as a potential treatment for depression – rendered laboratory mice seemingly impervious to conditions that would usually cause symptoms of anxiety or disturbance relating to the circumstances in which they had been placed.

Now, it appears that the scope of psychedelic drugs’ potential as a treatment for mental illness is expanding further still, after new information presented at the Psychedelic Science conference held last week in California suggested that psychedelics could be useful as a remedy for several mental illnesses.















Leave a reply